The pharmacologic management of obesity.
Cerda
J J
JJ
Division of Gastroenterology, Hepatology, University of Florida College of Medicine, USA.
D000328:Adult; D019440:Anti-Obesity Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001067:Appetite Depressants / Q000008:administration & dosage / Q000627:therapeutic use*; D015992:Body Mass Index; D001835:Body Weight; D002908:Chronic Disease; D005277:Fenfluramine / Q000008:administration & dosage / Q000627:therapeutic use; D005544:Forecasting; D006801:Humans; D020738:Leptin; D009765:Obesity / Q000145:classification / Q000188:drug therapy* / Q000235:genetics; D010645:Phentermine / Q000008:administration & dosage / Q000627:therapeutic use; D011506:Proteins / Q000235:genetics / Q000502:physiology; D014481:United States; D014486:United States Food and Drug Administration
D019440:Anti-Obesity Agents; D001067:Appetite Depressants; D020738:Leptin; D011506:Proteins; D005277:Fenfluramine; D010645:Phentermine